Search

Search Constraints

You searched for: Author/Creator Mattison, Donald

Search Results

1. Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease. Issue 3 (24th December 2015)

4. Challenges and opportunities in the risk assessment of existing substances in Canada: lessons learned from the international community. (2017)

5. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy. Issue 1 (December 2016)

6. Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an "at‐risk" population of pregnant women: Influenza as a case study. Issue 10 (8th October 2014)

7. Patterns and prevalence of medication use across the menstrual cycle among healthy, reproductive aged women. Issue 6 (8th March 2016)

8. Systemic quinolones and risk of acute liver failure III: A nested case–control study using a US electronic health records database. Issue 8 (31st March 2021)

9. Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system. Issue 2 (1st February 2022)

10. The role of human biological monitoring in health risk assessment. (2017)